TENET HEALTHCARE ($THC) posted quarterly earnings results for Q4 2025 on Wednesday, February 11th. The company reported earnings of $4.70 per share, beating estimates of $4.09 by $0.61. The company also reported revenue of $5,527,000,000, beating estimates of $5,526,606,223 by $393,777.
You can see Quiver Quantitative's $THC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TENET HEALTHCARE Insider Trading Activity
TENET HEALTHCARE insiders have traded $THC stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- SAUMYA SUTARIA (CEO) has made 0 purchases and 2 sales selling 78,762 shares for an estimated $15,026,139.
- TAMMY ROMO has made 0 purchases and 6 sales selling 27,500 shares for an estimated $5,563,324.
- R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 13,322 shares for an estimated $2,732,438.
- LISA Y FOO (EVP, Chief Operating Officer) sold 8,000 shares for an estimated $1,436,240
- CHRISTOPHER S. LYNCH has made 0 purchases and 2 sales selling 3,960 shares for an estimated $698,560.
- RICHARD W FISHER sold 2,500 shares for an estimated $521,075
- NADJA WEST sold 2,178 shares for an estimated $430,089
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TENET HEALTHCARE Hedge Fund Activity
We have seen 339 institutional investors add shares of TENET HEALTHCARE stock to their portfolio, and 348 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMINENCE CAPITAL, LP added 1,109,450 shares (+inf%) to their portfolio in Q3 2025, for an estimated $225,262,728
- BOSTON PARTNERS added 889,283 shares (+39.4%) to their portfolio in Q3 2025, for an estimated $180,560,020
- CITADEL ADVISORS LLC removed 772,360 shares (-42.2%) from their portfolio in Q3 2025, for an estimated $156,819,974
- AQR CAPITAL MANAGEMENT LLC added 720,160 shares (+62.3%) to their portfolio in Q3 2025, for an estimated $146,221,286
- INVESCO LTD. removed 681,050 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $138,280,392
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 606,326 shares (-20.7%) from their portfolio in Q3 2025, for an estimated $123,108,431
- HOLOCENE ADVISORS, LP removed 584,404 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $118,657,388
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TENET HEALTHCARE Government Contracts
We have seen $270,000 of award payments to $THC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STERILE PROCESSING SERVICES: $135,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
TENET HEALTHCARE Congressional Stock Trading
Members of Congress have traded $THC stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 2 purchases worth up to $65,000 on 12/10, 09/03 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
TENET HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- Barclays issued a "Overweight" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
- RBC Capital issued a "Outperform" rating on 10/30/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/29/2025
To track analyst ratings and price targets for TENET HEALTHCARE, check out Quiver Quantitative's $THC forecast page.
TENET HEALTHCARE Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $253.0 on 02/03/2026
- Stephen Baxter from Wells Fargo set a target price of $229.0 on 01/07/2026
- Ryan Langston from TD Cowen set a target price of $230.0 on 01/07/2026
- Jason Cassorla from Guggenheim set a target price of $257.0 on 12/02/2025
- Andrew Mok from Barclays set a target price of $240.0 on 11/21/2025
- Benjamin Rossi from JP Morgan set a target price of $230.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $240.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
